Zimmer Biomet (ZBH) PT Raised to $105 at Bernstein SocGen Group

Bernstein SocGen Group analyst Lee Hambright raised the price target on Zimmer Biomet (NYSE: ZBH) to $105.00 (from $100.00) while maintaining a Market Perform rating.

The analyst commented: "We rate ZBH Market-Perform with a price target of $105 (previously $100) using a P/E multiple of 12.0x (up from11.5x) against our forward Q5-Q8 EPS of $8.76 (previously $8.66). The story is improving, and it could get better if the company can execute on its plan for steep growth acceleration in 2H25."

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Viking Holdings (VIK) PT Raised to $82 at Mizuho
• Deere (DE) PT Raised to $585 at JPMorgan